Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 327
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00146055 | Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood | ||
| NCT03242915 | Pembrolizumab Plus Chemotherapy in NSCLC With Targetable Genetic Alterations After Progression on Targeted Agents | ||
| NCT02331368 | Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma | ||
| NCT00005598 | Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome | ||
| NCT07481344 | SunBeast: Evaluating UV Protective Behaviors and Education Interventions Among Ultrarunners | ||
| NCT04754399 | Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias | ||
| NCT06616155 | Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer | ||
| NCT00573378 | Imatinib or Nilotinib With Pegylated Interferon-α2b in Chronic Myeloid Leukemia | ||
| NCT01661062 | A Study Using Cone Beam CT for Head and Neck Cancer | ||
| NCT03559049 | Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung Cancer | ||
| NCT00176748 | Treatment for Patients With Metastatic Thyroid Cancer | ||
| NCT00151073 | Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate | ||
| NCT03515356 | Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy | ||
| NCT03927105 | Nivolumab and the Antagonistic CSF-1R Monoclonal Antibody Cabiralizumab (BMS-986227) in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma | ||
| NCT00843375 | Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas | ||
| NCT00570531 | Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma | ||
| NCT01988675 | MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-Barrier | ||
| NCT00189137 | Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma | ||
| NCT02729194 | Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma | ||
| NCT00230399 | Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer | ||
| NCT05162846 | Michigan Genetic Hereditary Testing (MiGHT) | ||
| NCT02037230 | Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas | ||
| NCT06228768 | Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer | ||
| NCT01975597 | Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer | ||
| NCT04518748 | Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy. | ||
| NCT00726180 | Use of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast Cancer | ||
| NCT04396808 | Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer | ||
| NCT03556904 | FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE) | ||
| NCT00320749 | Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer | ||
| NCT02097732 | Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery | ||
| NCT00599131 | Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE) | ||
| NCT00555477 | Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure | ||
| NCT02059213 | A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer | ||
| NCT02158975 | Open-label, Phase II Study of MLN9708 in Patients With Relapsed/Refractory Cutaneous and Peripheral T-cell Lymphomas | ||
| NCT00639717 | Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant | ||
| NCT03286114 | Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab | ||
| NCT05867667 | Cardiac Rehabilitation to Improve Breast Cancer Outcomes | ||
| NCT00724568 | Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma | ||
| NCT01285635 | A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck | ||
| NCT02013453 | A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer | ||
| NCT03601819 | Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders | ||
| NCT01579812 | Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in Gynecologic Patients | ||
| NCT01519219 | Assessment Of Liver Function in Patients Undergoing Hepatic Irradiation | ||
| NCT01288534 | Hypofractionated Stereotactic Body Radiation Therapy (SBRT) | ||
| NCT03135171 | Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to Trastuzumab | ||
| NCT04827446 | Lighting Intervention for Cancer-related Fatigue | ||
| NCT00995488 | Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer | ||
| NCT01700010 | Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer | ||
| NCT01409681 | A Multi-Centered Trial Evaluating the Role of Vitamin D Metabolism in Non-Small Cell Lung Cancer | ||
| NCT04272645 | Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer |
